Eric J. Small
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Radiopharmaceutical Chemistry and Applications, Cancer, Lipids, and Metabolism, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer(2010)5,446 cited
- → Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer(2004)3,681 cited
- → Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy(2012)2,765 cited
- → Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group(2008)2,225 cited
- → Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology(2019)1,555 cited
- → Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3(2016)1,550 cited
- → Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study(2015)1,334 cited
- → Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer(2018)1,305 cited
- → Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1- 13 C]Pyruvate(2013)1,243 cited
- → Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate Cancer(2006)1,102 cited